Multiple unit dosage form farmaêutica orally in tablet process for preparation of same for inhibition of gastric acid secretion in mammals and humans for the treatment of diseases in.Gastrointestinal

摘要

A new pharmaceutical multiple unit tableted dosage form containing as active substance an acid labile H+K+-ATPase inhibitor or an alkaline salt thereof or one of its single enantiomers or an alkaline salt thereof, a method for the manufacture of such a formulation, and the use of such a formulation in medicine.